Gunderson Dettmer advised Parallel Bio on the deal.Parallel Bio, a biotechnology company, announced its $4.3 million seed round led by Refactor Capital. Parallel Bio created a human…
Parallel Bio’s $4.3 Million Seed Funding


Gunderson Dettmer advised Parallel Bio on the deal.Parallel Bio, a biotechnology company, announced its $4.3 million seed round led by Refactor Capital. Parallel Bio created a human…
…